Caring for a Loved One with CCA: A Son’s Perspective

June/July 2022, Vol 3, No 2

At the 2022 Cholangiocarcinoma Foundation annual meeting, Ambuj Srivastava shared his experience as a current caregiver for his dad who was diagnosed with stage 2 extrahepatic cholangiocarcinoma (CCA). Ambuj lives in Toronto, Canada, with his wife, daughter, and parents. He is a mentee and patient advocate with the Cholangiocarcinoma Foundation.

Following a diagnosis of stage 2 extrahepatic CCA in September 2019, Ambuj’s father underwent surgery, chemotherapy, and immunotherapy. During that time, he “dealt with many monthly ER visits to the hospital due to blockages or infections.”

Ambuj described the initial days following his father’s diagnosis. “I was multitasking at work and home, talking to multiple specialists, coordinating meetings. There was a whole lot of information to process, stress, anxiety, confusion—it all became quite challenging,” Ambuj said. “We went through a rollercoaster of emotions. It was difficult and caused many restless nights.”

According to Ambuj, the caregiver role is a dynamic one, encompassing caregiving, care living, and care loving:

  • Caregiving is “a privilege for providing or taking care of a loved one during their most precious and maybe limited moments.”
  • Care living is “changing lifestyle, expectations, and boundaries for what you can and cannot do.”
  • Care loving is “self-care, which is usually given the least priority, but it is the glue that will keep you and your responsibilities together with a good support system in place.”

The biggest role is to advocate for the needs of the loved one, according to Ambuj. “It’s important to ensure that your loved one feels like they are in control of their health decisions,” he said. “Empower them to speak up and voice their concerns.”

Ambuj shared some pearls of wisdom that have helped him navigate his caregiving journey:

  • Define limits. Caregiving is a priority and balancing act that can become challenging. His advice: Plan for 1 day at a time.
  • Create a support system. This could include family, friends, support groups, managers, coworkers, mentors, social workers, and palliative support personnel—anyone who can provide physical and emotional assistance. Palliative support is important and does not necessarily mean the end of the road; it can provide many benefits to patients and their families.
  • Avoid caregiver burnout by assessing and managing with an appropriate support system.
  • Adopt the right mindset because “the first line of treatment is attitude.”

Ambuj recounted how his initial thinking about caregiving changed drastically after this experience. “I thought it was something that you would do for your loved one without any titles or any expressions or words,” he said. “But I now understand the importance of verbalizing and acknowledging the role of a caregiver.”

Ambuj concluded by saying, “Caregivers are like sidekicks to the real superheroes of this journey, Robin to the Batman. Superheroes are cool but I think sidekicks are pretty badass, too.”

Related Items

Artificial Intelligence and Clinical Experience: Shaping the Future of CCA Care
June/July 2026, Vol 7, No 2
A look at how the synergy between artificial intelligence and clinical expertise is potentially shaping the outlook of cholangiocarcinoma care.
Cholangiocarcinoma Clinical Trials: Debunking Myths, Uncovering Facts, and Exploring Opportunities
June/July 2026, Vol 7, No 2
Uncover how clinical trials are transforming cholangiocarcinoma treatment, offering patients personalized therapies, expanded options, and new hope for the future.
The Changing Paradigm of Cellular Immunotherapy in Cholangiocarcinoma
June/July 2026, Vol 7, No 2
Explore how cellular immunotherapy, from tumor-infiltrating lymphocytes to circulating tumor-reactive T cells, is expanding the treatment landscape for cholangiocarcinoma.
Antibody-Drug Conjugates in Biliary Tract Cancers
June/July 2026, Vol 7, No 2
Antibody-drug conjugates show potential in cancer treatment and may signal new possibilities for biliary tract cancer patients in this significant exploration.
Advancing Hepatic Arterial Infusion Pump Chemotherapy for Intrahepatic Cholangiocarcinoma: Boosting Survival and Quality of Life
June/July 2026, Vol 7, No 2
Hepatic arterial infusion pump chemotherapy is transforming treatment for intrahepatic cholangiocarcinoma by improving survival rates and enhancing quality of life.
Exploring Protein Arginine Methyltransferases as Promising Therapeutic Targets in Cholangiocarcinoma
June/July 2026, Vol 7, No 2
Targeting protein arginine methyltransferases offers a promising new approach to combat cholangiocarcinoma by suppressing tumor growth and enhancing immune responses.
Advancing CAR T Cell Therapy for Cholangiocarcinoma
June/July 2026, Vol 7, No 2
Discover how emergent research on CAR T-cell therapy is paving the way for new possibilities in cholangiocarcinoma treatment.
Overcoming Therapeutic Resistance in Cholangiocarcinoma: Exploring Combination Strategies and Adaptive Lineage States
June/July 2026, Vol 7, No 2
Cutting-edge research on therapeutic resistance and innovative combination strategies is adding new possibilities to the fight against cholangiocarcinoma.
Biomarker Discovery and Early Detection in CCA
June 2025, Vol 6, No 2
Experts unveiled a roadmap for translating cutting-edge biomarkers into clinical practice, paving the way for improved early detection and personalized care in high-risk populations with cholangiocarcinoma (CCA).
Translational Science and Discovery in CCA
June 2025, Vol 6, No 2
Leading experts explored groundbreaking advancements in tumor microenvironments, biomarker validation, and innovative therapies, paving the way for transformative precision medicine in cholangiocarcinoma (CCA) care.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Profession or Role
Primary Specialty or Disease State